Tina Vilsbøll

Tina Vilsbøll

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology


  1. 2021
  2. Published

    In patients with controlled acromegaly, indices of glucose homeostasis correlate with IGF-1 levels rather than with type of treatment

    Decock, A., Verroken, C., Van de Velde, F., Vilsbøll, Tina, Holst, Jens Juul, T’Sjoen, G. & Lapauw, B., 2021, In: Clinical Endocrinology. 95, 1, p. 65-73

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Published

    Increased glucagon sensitivity in totally pancreatectomised patients

    Rix, I., Lund, A., Garvey, Lene Heise, Owen, K., Hansen, C., van Hall, Gerrit, Holst, Jens Juul, Vilsbøll, Tina & Knop, Filip Krag, 2021, In: Diabetologia. 64, SUPPL 1, p. 118-119 226.

    Research output: Contribution to journalConference abstract in journalResearch

  4. Published

    Intention and perceptions of healthy eating versus actual intake among patients with type 1 and type 2 diabetes and the general population

    Ewers, B., Sørensen, M. R., Fagt, S., Diaz, L. J. & Vilsbøll, Tina, 2021, In: Patient Preference and Adherence. 15, p. 2027-2037 11 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Published

    Liraglutide decreases postprandial fibroblast growth factor 19 and glucagon-like peptide 2, and increases postprandial cholecystokinin in individuals with obesity

    Bronden, A., Nerild, H. H., Nexoe-Larsen, C. C., Hellmann, P. H., Baekdal, M., Gether, I. M., Gillum, M. P., Hartmann, Bolette, Knudsen, L. B., Jacobsen, L. V., Rehfeld, Jens Frederik, Holst, Jens Juul, Vilsbøll, Tina, Sonne, D. P. & Knop, Filip Krag, 2021, In: Diabetologia. 64, SUPPL 1, p. 94-94 177.

    Research output: Contribution to journalConference abstract in journalResearch

  6. Published

    Liraglutide does not change bone turnover in clozapine- and olanzapine-treated schizophrenia overweight patients with prediabetes – randomized controlled trial

    Maagensen, H., Larsen, J. R., Jørgensen, Niklas Rye, Fink-Jensen, Anders & Vilsbøll, Tina, 2021, In: Psychiatry Research. 296, 113670.

    Research output: Contribution to journalJournal articleResearchpeer-review

  7. Published

    Once-weekly subcutaneous semaglutide treatment for persons with type 2 diabetes: Real-world data from a diabetes out-patient clinic

    Hansen, K. B., Svendstrup, M., Lund, A., Knop, Filip Krag, Vilsbøll, Tina & drb459, drb459, 2021, In: Diabetic Medicine. 38, 10, p. e14655

    Research output: Contribution to journalReviewResearchpeer-review

  8. Published

    Potential kidney protection with liraglutide and semaglutide: Exploratory mediation analysis

    Mann, J. F. E., Buse, J. B., Idorn, T., Leiter, L. A., Pratley, R. E., Rasmussen, S., Vilsbøll, Tina, Wolthers, B. & Perkovic, V., 2021, In: Diabetes, Obesity and Metabolism. 23, 9, p. 2058-2066 9 p.

    Research output: Contribution to journalJournal articleResearchpeer-review

  9. Published

    Prognostic Value of Early Systolic Lengthening by Strain Imaging in Type 2 Diabetes

    Brainin, P., Biering-Sørensen, Tor, Jensen, M. T., Møgelvang, R., Fritz-Hansen, T., Vilsbøll, Tina, Rossing, Peter & Jørgensen, P. G., 2021, In: Journal of the American Society of Echocardiography. 34, 2, p. 127-135

    Research output: Contribution to journalJournal articleResearchpeer-review

  10. Published

    Prognostic and comparative performance of cardiovascular risk markers in patients with type 2 diabetes

    Busch, N., Jensen, M. T., Goetze, Jens P. , Schou, Morten, Biering-Sørensen, Tor, Fritz-Hansen, T., Andersen, H. U., Vilsbøll, Tina, Rossing, Peter & Jørgensen, P. G., 2021, In: Journal of Diabetes. 13, 9, p. 754-763

    Research output: Contribution to journalJournal articleResearchpeer-review

  11. Published

ID: 33056950